US Tissue Diagnostics Market to Witness Rapid Growth by 2025
The US tissue diagnostics market is anticipated to grow at a CAGR 6.9% during the forecast period. The US is dominating the tissue diagnostic market in terms of revenue and R&D. Government and private ventures are contributing significantly to the growth of the US tissue diagnostic market. The implementation of the Affordable Care Act boosted the healthcare system of U.S. New insurance policies and reforms in the healthcare system are expected to create significant opportunities for the tissue diagnostic market. The healthcare spending is highest in the US which is estimated to be $8,608 per person. Tissue diagnostics market is triggered by the significant demand for diagnosis and treatment for cancer and related diseases. According to the American Institute of Cancer, Research Cancer is considered to be a menace that is responsible for 300 fatalities in every 0.1 million cases. The diagnosis cost, tests, stain and other diagnostic devices are highest in the U.S. compared to other regions.
(Get 25% Discount on Buying this Report)
To Request a Sample of our Report on US
Tissue Diagnostics Market: https://www.omrglobal.com/request-sample/us-tissue-diagnostics-market
Most of the key players are based in
the US contributing to the growth of the tissue diagnostics market through
mergers and acquisitions, partnerships and collaboration. For instance, Danaher
is expected to acquire Cepheid at $ 4 billion which is a molecular diagnostics
company that develops manufactures and markets molecular systems and tests in
the US. Procedure volume growth is significantly high in the US due to the huge
prevalence of cancer patients, improving healthcare infrastructure, improved
insurance coverage and reimbursement policies. The other key factors that are
driving the US market of tissue diagnostics market include reforms in the
healthcare sector, rising awareness for tissue diagnostics and adoption of
personalized medicines among others. Major players those are active in the
market that includes Abbott Laboratories, Inc., Agilent Technologies, Biogenex
Laboratories, Cell Signaling Technology, Inc., Bio SB, Danaher Corporation,
Life Technologies, Thermo Fisher Scientific, Inc and Sigma-Aldrich.
A
full Report of US Tissue Diagnostics Market is
Available @ https://www.omrglobal.com/industry-reports/us-tissue-diagnostics-market
US Tissue Diagnostics Market Segmentation
By Diagnostic Techniques
·
Prostate-Specific Antigen Test (PSA)
·
Digital Rectal Examination
·
Prostate Biopsy
·
Imaging Techniques
By Therapeutics
·
Hormonal Therapy
·
Chemotherapy
·
Immunotherapy
·
Radiation Therapy
·
Targeted Therapy
·
Surgery
Company Profiles
·
Alere, Inc.
·
Becton, Dickinson and Co.,
·
Bio SB
·
Biogenex Laboratories
·
BioMérieux SA
·
Cell Signalling Technology, INC.
·
DiaGenic ASA
·
Prometheus Laboratories
·
QIAGEN AG
·
Stryker Corp.
Reasons to buy from us –
1. We cover more than 15 major industries,
further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for
investigation.
4. Our expert research analysts answer all your
questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market
research and consulting company known for its crisp and concise reports. The
company is equipped with an experienced team of analysts and consultants. OMR
offers quality syndicated research reports, customized research reports,
consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
Comments
Post a Comment